Schizophrenia — A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia
Citation(s)
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ALKS 9072 in Subjects With Chronic Stable Schizophrenia